Angelique Barreto, MD — Oklahoma City, Oklahoma

Angelique Barreto, MD is a clinical research site located in Oklahoma City, Oklahoma, United States 73135.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Angelique Barreto, MD has participated in 2 clinical trials.

Therapeutic areas: Partial Seizures, Epilepsies, Partial, Diabetic Neuropathy, Painful.

Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Angelique Barreto, MD?

Angelique Barreto, MD has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Angelique Barreto, MD conducted?

Angelique Barreto, MD has 2 clinical trials on record. Their work covers Partial Seizures, Epilepsies, Partial, Diabetic Neuropathy, Painful.

Is Angelique Barreto, MD accredited by Crixeo Health?

Angelique Barreto, MD has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Angelique Barreto, MD?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.